1-5 of 5
Georgi G. Mihaylov, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Cell Immune Signatures in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Treated with Nilotinib: An ENEST1st Sub Study

Stein-Erik Gullaksen, MSc, Jørn Skavland, PhD, Krzysztof Warzocha, MD PhD, Sonia Gavasso, PhD, Vinko Tosevski, PhD, Noortje Thielen, MDPhD, Jaroslava Voglova, MD, Augustin Ferrant, MD PhD, Werner Linkesch, MD, Josef Thaler, MD, Alois Lang, MD, Jesper Stentoft, Tobias Gedde-Dahl, MDPhD, Henrik Hjorth-Hansen, MD PhD, Waleed Majeed, MD, Gregor Verhoef, MD PhD, Andrzej Hellmann, MD PhD, Georgi G. Mihaylov, MD PhD, Claudia Dumrese, PhD, Frank Giles, MDMB, Andreas Hochhaus, MD, Sieghart Sopper, PhD, Leif Stenke, MD PhD, Boris Labar, MD PhD, Jeroen Janssen, MD, Kimmo Porkka, MD PhD, Gert J. Ossenkoppele, MD PhD, Satu Mustjoki, MD PhD, Dominik Wolf, MD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4022.
https://doi.org/10.1182/blood.V126.23.4022.4022
Published: 2015
Journal Articles

Baseline Characteristics of CML Patients Accross Europe - Comparing Real-World Patients with Patient Collectives Included in Clinical Trials

Michele Baccarani, MD, Verena Sophia Hoffmann, Gianantonio Rosti, Fausto Castagnetti, Susanne Saussele, MD, Joelle Guilhot, PhD, Bengt Simonsson, MD PhD, Juan Luis Steegmann, MD PhD, Jiri Mayer, Prof., MD PhD, Karel Indrak, MD PhD, Anna G. Turkina, MD PhD, Andrey Zaritskey, Boris Labar, MD PhD, Irena Zupan, MD PhD, Noortje Thielen, MD, Richard E. Clark, MD, Josef Thaler, MD, Frederiki Melanthiou, Hele Everaus, MD PhD, Kimmo Porkka, MD PhD, Andrija Bogdanovic, Gabriele Schubert-Fritschle, Dr., Panagiotis Panagiotidis, MDPhD, Tamas Masszi, MD, Sandra Lejniece, PhD MD, Laimonas Griskevicius, Andrzej Hellmann, Witold Prejzner, Tomasz Sacha, MD PhD, Antonio Almeida, MD PhD, Irina Dyagil, Adriana Colita, MD, Georgi G. Mihaylov, MD PhD, Rüdiger Hehlmann, MD, Joerg Hasford, MD, Doris Lindoerfer
Journal: Blood
Blood (2014) 124 (21): 3160.
https://doi.org/10.1182/blood.V124.21.3160.3160
Published: 2014
Journal Articles

Carfilzomib, Lenalidomide, and Dexamethasone vs Lenalidomide and Dexamethasone in Patients (Pts) with Relapsed Multiple Myeloma: Interim Results from ASPIRE, a Randomized, Open-Label, Multicenter Phase 3 Study

A. Keith Stewart, MD, S. Vincent Rajkumar, MD, Meletios A. Dimopoulos, Tamás Masszi, MD PhD, Ivan Spicka, Prof. MD PhD, Albert Oriol, MD, Roman Hájek, MD PhD Prof. of Oncology, Laura Rosiñol, MD PhD, David S. Siegel, MD PhD, Georgi G. Mihaylov, MD PhD, Veselina Goranova-Marinova, MD PhD, Péter Rajnics, MD PhD, Aleksandr Suvorov, MD, Ruben Niesvizky, MD, Andrzej Jakubowiak, MD PhD, Jesus F. San Miguel, Heinz Ludwig, Univ. Prof. Dr., Naseem Zojwalla, MD, Margaret E. Tonda, PharmD, Biao Xing, PhD, Philippe Moreau, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 79.
https://doi.org/10.1182/blood.V124.21.79.79
Published: 2014
Journal Articles

Rituximab Maintenance after Chemoimmunotherapy Induction in 1 st and 2 nd Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial

Richard Greil, MD, Petra Obrtlikova, MD PhD, Lukas Smolej, MD PhD, Tomas Kozak, MDPhD, Michael Steurer, MD, Johannes Andel, MD, Josef Thaler, MD, Eva Mikuskova, MD, Liana Gercheva, MD, Thomas Nösslinger, MD, Miriam Ladicka, MD, Michael Girschikofsky, MD, MikulᚠHrubiško, MD PhD, Prof., Ulrich Jäger, MD, Michael A. Fridrik, MD, Martin Pecherstorfer, MD, Eva Kralikova, MD, Cristina Burcoveanu, MD, Stefcho Goranov, MD, Jana Jurkovikova, MD, Andreas L. Petzer, MD, Georgi G. Mihaylov, MD PhD, Julian Raynov, MD, Horst Oexle, MD, August Zabernigg, MD, Emilia Flochova, MD PhD, Stanislav Palasthy, MD, Thomas Melchardt, MD, Jiri Mayer, MD, Alexander Egle, MD
Journal: Blood
Blood (2014) 124 (21): 20.
https://doi.org/10.1182/blood.V124.21.20.20
Published: 2014
Journal Articles

Early PK-Analysis Predicts Molecular Response In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib

Dominik Wolf, MD, Jorn Skavland, PhD, Christoph Seger, PhD, Sieghart Sopper, PhD, Wiktor-Wieslaw Jedrzejczak, MD, PhD, Dubravka Sertic, MD, Jaroslava Voglova, MD, Satu Mustjoki, MD PhD, Leif Stenke, MD, PhD, Augustin Ferrant, MD, PhD, Richard Greil, MD, Alois Lang, MD, Josef Thaler, MD, PhD, Werner Linkesch, MD, Antica Duletić-Načinović, MD , PhD, Andrzej Hellmann, MD, PhD, Georgi G. Mihaylov, MD, PhD, Tobias Gedde-Dahl, III, MD, PhD, Henrik Hjorth-Hansen, MD, PhD, Waleed Majeed, MD, Jesper Stentoft, MD, Gregor Verhoef, M.D. Ph.D., Jan Van Droogenbroeck, MD, Ute Mark, Jens Haenig, Nidas Jurjonas, Frank Giles, MD MB, Andreas Hochhaus, MD, Kimmo Porkka, MD, PhD, Gert J. Ossenkoppele, MD PhD, Bjorn T. Gjertsen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1485.
https://doi.org/10.1182/blood.V122.21.1485.1485
Published: 2013